'Glenmark's nasal spray can cut covid viral load by 99%

Drugmaker Glenmark and its Canadian partner SaNOtize on Wednesday said that the nitric oxide nasal spray (NONS) has met the key endpoints and demonstrated reduction of Covid viral load by 93.7% in 24 hours and 99% in 48 hours in the phase-3 clinical trials conducted in India. The randomised, double-blind phase 3 trial was conducted by Glenmark in 306 vaccinated and non-vaccinated adults of symptomatic mild Covid-19 across 20 clinical sites in India during Delta and Omicron waves.